Secker-Walker L M, Chessells J M, Stewart E L, Swansbury G J, Richards S, Lawler S D
Department of Cytogenetics, Royal Marsden Hospital, Oxford.
Br J Haematol. 1989 Jul;72(3):336-42. doi: 10.1111/j.1365-2141.1989.tb07713.x.
Cytogenetic, clinical and laboratory features at diagnosis were examined in a group of 80 children with acute lymphoblastic leukaemia (ALL) who had been followed up for a minimum of 5 1/2 years. The 17 (21%) with high hyperdiploidy tended to have low leucocyte counts and common ALL, but their favourable outcome (75% event-free survival) was independent of these factors. No patient with hypodiploidy survives while the pseudodiploid and normal groups have an intermediate prognosis. Cytogenetic analysis showed examples of patients with the well-recognized translocations and a number with apparently unique ones. Among the latter were some long-term survivors. We conclude that cytogenetic analysis identifies a good risk group of patients who remain well on long-term follow-up, but that the presence of a translocation does not necessarily imply a poor outcome.
对一组80例急性淋巴细胞白血病(ALL)患儿进行了诊断时的细胞遗传学、临床和实验室特征检查,这些患儿至少随访了5年半。17例(21%)高超二倍体患儿往往白细胞计数低且为普通型ALL,但他们良好的预后(75%无事件生存率)与这些因素无关。亚二倍体患儿无一存活,而假二倍体和正常组预后中等。细胞遗传学分析显示有公认易位的患者实例,还有一些明显独特易位的患者。后者中有一些长期存活者。我们得出结论,细胞遗传学分析可识别出一组长期随访情况良好的低风险患者,但存在易位并不一定意味着预后不良。